| Name | APOL1-IN-1 |
|---|
| Description | APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD)[1]. |
|---|---|
| Related Catalog | |
| Target |
Apolipoprotein LI (APOL1)[1] |
| References |
[1]. Brodney M, et, al. Inhibitors of apol1 and methods of using same. WO2020131807A1. |
| Molecular Formula | C21H20FN3O3 |
|---|---|
| Molecular Weight | 381.40 |